Specifically, IL‐6 has been shown to support tumor progression by acting directly on cancer cells and by promoting immune tolerance through the expansion of myeloid‐derived suppressor cells (MDSCs) [17, 23, 24]. This evidence concerns the gene IL6 and neoplasm.